, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary.SUNNYVALE, Calif., Ma(GLOBE NEWSWIRE) - BioCardia®, Inc. Not an offer or recommendation by Stocktwits. (BCDA) Stock Price Today, News, Quotes, FAQs and Fundamentals More Advertisement 3rd Party Ad. (BCDA) Stock Price Today, News, Quotes, FAQs and Fundamentals Advertisement 3rd Party Ad.
(BCDA): $1.98 -0.02 (-1.00%) POWR Rating Component Grades Sign Up to See Ratings.FREE! We have 9 different ratings for every stock to help you appreciate its future potential. (BCDA) Social Stream BCDA Home News Ratings Charts Social Price Target BioCardia, Inc. BCDA Conversations From StockTwits BioCardia, Inc. The average twelve-month price prediction for BioCardia is $6.33 with a high price target of $9.00 and a low price target of $4.00. According to the issued ratings of 2 analysts in the last year, the consensus rating for BioCardia stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for BCDA.($0.40M), Renaissance Technologies LLC ($0.32M), Family Management Corp ($0.14M), CM Management LLC ($99K), Geode. Bcda stocktwitsOf the 12 institutional investors that purchased BioCardia stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($0.60M), Vanguard Group Inc.
0 kommentar(er)
